Leprosy and tuberculosis are the two major diseases caused by mycobacteria (2) . Leprosy is a chronic infectious disease that is endemic in tropical and subtropical regions, where it afflicts 10 to 15 million persons (2) . Leprosy is caused by the obligate intracellular parasite Mycobacterium leprae, which has particular affinity for skin, nerve, and muscle tissue. Tuberculosis is also most prevalent in the developing and tropical countries, with about 10 million new cases each year and an annual mortality of 3 million persons (15) . Tuberculosis results from a respiratory infection with Mycobacterium tuberculosis. If not restricted by immune responses, these facultative intracellular parasites can disseminate from the lung to other major organs of the body and cause death.
Mycobacterium bovis bacillus Calmette-Gudrin (BCG) is an avirulent form of the bovine tubercle bacillus (6) . It is used throughout the world as a tuberculosis vaccine and is administered to about half of the infants in developing countries (22) . The efficacy of the BCG vaccine against tuberculosis has been assessed in eight well-controlled trials, with a wide range of results indicating 0 to 80% protection from the disease. The reasons for the variability are not clear and have been the source of some controversy (for a review, see reference 9). BCG vaccination can also provide immunological protection against leprosy, although again its efficacy varies from 20 to 80% (9, 10) . Importantly, the efficacy of protection against leprosy appears to parallel the efficacy of protection against tuberculosis.
The features of BCG that can provide immune protection against tuberculosis and leprosy are not known, although it is widely assumed that the immune response to antigens shared by the etiologic agents and BCG is crucial to its prophylactic effect. To study the antigens of the three mycobacteria, more than 50 antimycobacterial monoclonal antibodies have been examined for their antigen and species specificities in a number of laboratories (4, 5, 11, 14, 16, 26) (3, 4; Engers, Letter, 1986 ; T. Shinnick, unpublished results). In contrast, 7 of the 10 monoclonal antibodies directed against the 65-kDa antigen cross-reacted with proteins in lysates from all three mycobacteria in dot blots and Western blots (5; Engers, Letter, 1985; Engers, Letter, 1986 ). The seven cross-reacting antibodies have been shown to bind to at least four different epitopes (5, 11) .
The 65-kDa antigen also appears to be a major immunoreactive protein during the course of an infection with either M. leprae or M. tuberculosis, as well as after vaccination with BCG. Both antibody and T cells directed against this antigen can be detected in the sera of patients and vaccinated persons, and the responses appear to be directed against specific, as well as cross-reactive, epitopes present on the 65-kDa antigen (4, 8, 14, 17, 19, 20, 24) .
To study this shared, immunologically active antigen further, we compared the DNA sequences that encode the 65-kDa antigens of the three mycobacteria. The genes that encode the 65-kDa antigens of these three species were previously isolated from recombinant DNA libraries by using antibody probes (23, 24, 27 (1) based on homology studies with total genomic DNA, these results suggest that the 65-kDa antigen gene is more highly conserved than the bulk of the genomic DNA.
The deduced 65-kDa protein sequences are shown in Fig.  2 . The DNA sequences of the 65-kDa antigen genes were previously determined for BCG (25) , M. leprae (18) , and M. tuberculosis (24) . The -------D-C--------------------------P----------------GYISGYFVTDAERQEAVLEEPYILLVSSKVSTVKDLLPLLEKVIQAGKSLLIIAEDVEGEALSTL  -----------------------------------G-------------A---------- level of presentation or access of the region to the antibody binding site (i.e., conformational alterations). The latter consideration raises the often cited caveat that an amino acid(s) outside of the actual antibody binding site may play a role in the ability of the antibody to bind. MLIIIC8 (residues 527 to 541) maps to a highly divergent region that contains a one-amino-acid deletion in the M. tuberculosis sequence relative to the M. leprae sequence. In the amino-terminal 8 residues of this 15-amino-acid sequence, only one match is found, whereas the carboxy-terminal 6 residues all match, suggesting that MLIIIC8 may bind toward the aminoterminal portion of this region.
Overall, it appears that the 65-kDa antigen gene is a very highly conserved gene within a region (and genomes) of otherwise low homology. The high degree of conservation suggests that there has been strong evolutionary pressure to maintain the primary amino acid sequence of this protein, which ih turn suggests that the 65-kDa antigen is a biologically important pIotein in the mycobacteria. Furthermore, certain of the monoclonal antibodies reactive with the 65-kDa antigen can cross-react with antigens present in as many as 23 mycobacterial species (5), suggesting that this protein may be conserved throughout the Mycobacterium genus. Indeed, immunologically related proteins can be found in a wide range of procaryotes, suggesting even wider conservation. That is, based on antibody cross-reactivity patterns, similarly sized antigens (-58 to 65 kDa) are present in a number of bacteria including Escherichia coli, Legionella pneumophila, Pseudomonas aeruginosa, and Salmonella typhimurium (5; T. Shinnick, unpublished results), as well as in the rickettsial species Rickettsia mooseri, Rickettsia rickettsii (T. Shinnick, unpublished results), and Coxiella burnetii (M. Vodkin and J. Williams, personal communication). Finally, the carboxy-terminal third of the 65-kDa antigen displays about 65% homology with a 158-residue amino acid sequence deduced from an open reading frame present on a 595-base-pair fragment of the E. coli genome which was cloned in pRC23 (7) . This recombinant plasmid can complement a mutation in the ams gene, which is thought to influence mRNA stability in E. coli (7, 21 
